Search Prime Grants

P50CA092629

Project Grant

Overview

Grant Description
SPORE IN PROSTATE CANCER
Awardee
Sloan-Kettering Institute For Cancer Research
Funding Goals
TO PROVIDE AN ORGANIZATIONAL FOCUS AND STIMULUS FOR THE HIGHEST QUALITY CANCER RESEARCH THAT EFFECTIVELY PROMOTES INTERDISCIPLINARY CANCER RESEARCH AIMED TOWARD THE ULTIMATE GOAL OF REDUCING CANCER INCIDENCE, MORTALITY AND MORBIDITY. THE CANCER CENTER SUPPORT GRANT (CCSG) PROVIDES THE RESOURCES AND INFRASTRUCTURE TO FACILITATE THE COORDINATION OF INTERDISCIPLINARY PROGRAMS ACROSS A BROAD SPECTRUM OF RESEARCH FROM BASIC LABORATORY RESEARCH TO CLINICAL INVESTIGATION TO POPULATION SCIENCE. THE CCSG SUPPORTS SALARIES FOR SCIENTIFIC LEADERSHIP OF THE CENTER, SHARED RESOURCES FOR FUNDED CENTER INVESTIGATORS, CERTAIN ADMINISTRATIVE COSTS, PLANNING AND EVALUATION, AND DEVELOPMENTAL FUNDS FOR NEW RECRUITMENTS AND FEASIBILITY STUDIES.
Grant Program (CFDA)
93.397 - Cancer Centers Support Grants
Awarding / Funding Agency
National Cancer Institute (NCI) [HHS - NIH]
Place of Performance
New York, New York 100656007 United States
Geographic Scope
Single Zip Code
Related Opportunity
Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2021, 2022, and 2023 (P50 Clinical Trial Required) (PAR-20-305)
Analysis Notes
Amendment Since initial award the End Date has been extended from 08/31/11 to 08/31/27 and the total obligations have increased 1266% from $2,640,179 to $36,056,351.
Sloan-Kettering Institute For Cancer Research was awarded Project Grant P50CA092629 worth $36,056,351 from National Cancer Institute in September 2001 with work to be completed primarily in New York New York United States. The grant has a duration of 26 years and was awarded through assistance program 93.397 Cancer Centers Support Grants. The Project Grant was awarded through grant opportunity Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2021, 2022, and 2023 (P50 Clinical Trial Required).

Status
(Ongoing)

Last Modified 1/6/25

Period of Performance
9/14/01
Start Date
8/31/27
End Date
91.0% Complete

Funding Split
$36.1M
Federal Obligation
$0.0
Non-Federal Obligation
$36.1M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to P50CA092629

Subgrant Awards

Disclosed subgrants for P50CA092629

Transaction History

Modifications to P50CA092629

Additional Detail

Award ID FAIN
P50CA092629
SAI Number
P50CA092629-305647812
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Nonprofit With 501(c)(3) IRS Status (Other Than An Institution Of Higher Education)
Awarding Office
75NC00 NIH NATIONAL CANCER INSTITUTE
Funding Office
75NC00 NIH NATIONAL CANCER INSTITUTE
Awardee UEI
KUKXRCZ6NZC2
Awardee CAGE
6X133
Performance District
NY-12
Senators
Kirsten Gillibrand
Charles Schumer

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
National Cancer Institute, National Institutes of Health, Health and Human Services (075-0849) Health research and training Grants, subsidies, and contributions (41.0) $21,391,506 100%
Modified: 1/6/25